In vitro evaluation of ciclopirox as an adjuvant for polymyxin B against gram-negative bacteria

J Antibiot (Tokyo). 2015 Jun;68(6):395-8. doi: 10.1038/ja.2014.164. Epub 2015 Jan 14.

Authors

Kwang-sun Kim¹, Taeyeon Kim², Jae-Gu Pan²

Affiliations

¹ 1] Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea [2] Biosystems and Bioengineering, Korea University of Science and Technology, Daejeon, Korea.
² Superbacteria Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Korea.

PMID: 25586022
DOI: 10.1038/ja.2014.164

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Acinetobacter baumannii / drug effects*
Acinetobacter baumannii / growth & development
Anti-Bacterial Agents / chemistry
Anti-Bacterial Agents / pharmacology*
Antifungal Agents / pharmacology*
Ciclopirox
Drug Resistance, Multiple, Bacterial / drug effects
Drug Synergism
Escherichia coli / drug effects*
Escherichia coli / growth & development
Microbial Sensitivity Tests
Polymyxin B / agonists*
Polymyxin B / pharmacology
Pseudomonas aeruginosa / drug effects*
Pseudomonas aeruginosa / growth & development
Pyridones / pharmacology*

Substances

Anti-Bacterial Agents
Antifungal Agents
Pyridones
Ciclopirox
Polymyxin B